ARCHIVES

Durant Suggests Six Efforts Needed For Survival Of Clinical Research

This article is from The Cancer Letter archive.

Vol. 12 No. 22 | May 30, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: New RFA, Program Announcements Coming Up Soon From BCDB for Radiation, Breast Cancer Studies

December 7, 1979

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

60 Minutes To Air Segment On The “Deception at Duke”

February 10, 2012

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

January 29, 1988

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

FDA Proposes To Require Electronic Submission

May 3, 2002